Item 5. Implementation of the international drug control treaties (continued) (a) Changes in the scope of control of substances Chair: First, Commission will consider recommendations of WHO on 4 substances, namely: (a) Whether or not it wishes to include N-pyrrolidino protonitazene in Schedule I of the 1961 Convention as amended; (b) Whether or not it …
Colombia
Plenary — Tuesday afternoon session
Item 4. Strategic management, budgetary and administrative questions China: The Chinese government has consistently supported and actively participated in drug control efforts advocated by UNODC. UNODC has played an important role in supporting member states and taking measures to address the drug problems and provide technical assistance. China appreciates the positive efforts and results seen …
Opening of the 68th Session of the CND
Item 1. Election of officers CND Chair. It’s an honour to welcome you to the 68th session of the CND. I thank all my colleagues at the extended bureau and secretariat. With over 2,000 participants, this is one of the largest CNDs. The CND can be followed in Boardroom A and UN Web TV. The …
CND Reconvened 67th Session
Chair: Welcome back to the Reconvened 67th Session. We will continue the consideration on Item 4 on strategic management, budgetary and administrative questions. At our joint meeting with the CCPCJ yesterday, we considered under Agenda Item 4 the implementation of the consolidated for the biennium 2024-2025 for the UNODC. And the drugs proposed program plan …
CND Reconvened 67th Session – CND & CCPCJ joint meeting
MORNING SESSSION CCPCJ 1st VICE-Chair: Annotated Agenda. As you can see, it is proposed that the session today will address Item 4 on strategic management, budgetary, and administrative questions. As a joint meeting we are CND. Any outstanding elections for the FINGOV Bureau for 2024 will happen under that item as agreed upon by the …
CND Intersessional – Session 6 – Other Substantial Matters
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Other Substantial Matters proposed by Member States • Challenges to the identification of new illicit drugs: Discussion on strategies and approaches by laboratories to enhance the capacity of forensic personnel and harnessing technology to improve identification methods …